Kainova Therapeutics has dosed the first patient in Europe in [...]
Kainova Therapeutics has secured $32m CAD in a Series B [...]
Amorphical has appointed Eden Ben as chief executive officer, as [...]
Kainova Therapeutics has dosed the first patient in Europe in [...]
Kainova Therapeutics has secured $32m CAD in a Series B [...]
Amorphical has appointed Eden Ben as chief executive officer, as [...]